The market for oral thin film drugs is expected to reach US $6274.7 Million by 2030 registering a CAGR of 9.21% during the period forecast of 2023 to 2031. Oral thin films are drug delivery dosage device that is made up of a mono-polymeric thin film that is deposited in the mouth for a fast release of an active pharmaceutical ingredient (API) when placed on the tongue. The absorbed medicinal chemicals are then sent straight into the circulatory system. The popularity of oral thin film (OTF) medications can be attributed to the ease with which they are dissolved in the body. The increasing proportion of elderly people in the community has increased the demand for innovative approaches to the administration of drugs to treat and prevent chronic conditions such as diabetes. The growth of the market for oral thin film pharmaceuticals is anticipated to be helped along by an increase in the amount of money that businesses invest in research and development (R&D) to discover soluble treatments for a variety of diseases. When introduced in less developed nations, OTF medications have the potential to increase revenue for the market.
Acquestive and Cure Pharmaceutical remain the dominant players that are comparatively active and have strong market presence. Companies such as IntelGen corp are expected to witness significant opportunities during the forecast period. Sumitomo Diaippon and CL pharm are emerging players and are not very active as dominant market players. Tesa and Zim are expected to join the tier 1 market player club during the forecast period.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
This product will be delivered within 2 business days.
The rising incidence of Parkinson's disease is expected to stimulate consumer demand for OTFs
The increasing prevalence of target diseases as well as the benefits that come with using thin films is boosting the market for OTFs. For example, the Parkinson's Foundation 2021 estimated that more than 10.0 million people were living with Parkinson's disease around the world. According to another finding from the same survey, there were approximately one million people in the United States living with Parkinson's disease in the year 2021. Also, the probability of developing Parkinson's disease rises with age; as a result, the growing elderly population around the world is anticipated to have a beneficial impact on the market. In addition, a report published by the Parkinson's Foundation in 2021 projects that there will be an additional 1.2 million people affected with Parkinson's disease by the year 2030. This projection is based on current trends. It is generally agreed that oral thins are among the more successful therapies for Parkinson's disease. As a result, the rising incidence of Parkinson's disease is expected to stimulate consumer demand for oral thins, which will, in turn, drive the expansion of the market.Growth in investment in R&D of fast-dissolving oral films driving oral thin films market statistics
Oral film that dissolves quickly is the most recent and technologically advanced form of an oral solid dose. It provides increased versatility as well as comfort. Oral films that dissolve quickly improve the efficiency of APIs since they do not require chewing to dissolve in the oral cavity within minutes of coming into touch with saliva. Oral films also do not require the use of water during the administration process. Because of the strong blood flow and the ability of the oral mucosa to absorb substances, these medications are absorbed rapidly and have an immediate effect on the body. Because of these advantages, it is anticipated that the oral thin films business will experience growth over the next few years.Key Opportunities
The opportunity for the OTF market is in the expansion in the global sector that has been fuelled by a high level of tolerance, in addition to great benefits. The growth of the oral thin film market has been fuelled, in part, by the increased investment of major players in research and development (R&D). To strengthen their positions in the oral thin film market, major companies in this market are concentrating their efforts on the development of quickly dissolving oral thin films by employing novel platform technologies such as soul leaves, XGEL, and waferTab.Sublingual Film Products Dominating the Market
According to the most recent findings of an in-depth study on the oral thin films market, the sublingual film product segment held a substantial proportion in the year 2022. The sublingual mucosa has a high level of vascularization, which, along with the thin membrane structure, results in a high level of membrane permeability. The bioavailability of the sublingual mucosa is exceptionally high. Better permeability can be attributed to higher blood flow and lymphatic circulation, which circumvents the first-pass effect and leads to increased systemic bioavailability. Both of these factors contribute to the body's ability to absorb a substance.Neuro Segment to Dominate the Market by Indication
During the projected period, it is anticipated that the neurological segment disorders indication segment will have the largest share of the oral thin films market. The increased frequency of neurological illnesses around the world is one factor that can be attributed to the growth of this sector. In the European Union, neurological illnesses constitute the third most common reason for both disability and death in people under the age of 65. Therapies that need quick drug absorption, such as those for pain, allergies, sleep disorders, and disorders of the nervous system, are well suited for administration via oral thin films.North America to Remain as the Global Leader
The market for oral thin film medicines will be further propelled forward in the future by factors such as the growing demand for effective drug delivery routes and the acceptance of these routes in the region. North America is expected to continue its dominance concerning market revenues across the forecast period. In addition, a study that was published in the journal of the Migraine Research Foundation in September 2022 found that more than 39 million people in the United States suffer from migraines on an annual basis, with women being three times more likely than males to be affected by the condition. On the other hand, favorable regulations, rising levels of knowledge among the general population, and the introduction of innovative products would cause the Asia Pacific to be the geographical region with the most rapid expansion throughout the course of the projected period. The market for thin oral thin film pharmaceuticals is expected to profit further from the growing target population in the region, as well as the significant contributions made by India and China to the advancement of pharmaceutical technology.Market to Offer Significant Opportunities to Major Players During the Forecast Period
The major companies in the market have increased investment significantly in research and development (R&D), which has been a driving force behind the market's expansion towards oral thin films. Companies of significant size that are active in the market for oral thin films are concentrating their efforts on making investments in the research and development of fast-dissolving oral thin films. This is done to bolster their position in the market through the implementation of new platform technologies such as soluleaves, XGEL, and waferTab. Research and development contribute to the creation of novel solutions that have the potential to be more practical, productive, and economical in the delivery of drugs.Acquestive and Cure Pharmaceutical remain the dominant players that are comparatively active and have strong market presence. Companies such as IntelGen corp are expected to witness significant opportunities during the forecast period. Sumitomo Diaippon and CL pharm are emerging players and are not very active as dominant market players. Tesa and Zim are expected to join the tier 1 market player club during the forecast period.
Historical & Forecast Period
This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Oral Thin Film Drugs market are as follows:- Research and development budgets of manufacturers and government spending
- Revenues of key companies in the market segment
- Number of end users and consumption volume, price and value.
- Geographical revenues generate by countries considered in the report
- Micro and macro environment factors that are currently influencing the Oral Thin Film Drugs market and their expected impact during the forecast period.
Market Segmentation
Product
- Sublingual Film
- Fully Dissolving Buccal Film
Indication
- Migrainet
- Schizophrenia
- Alzheimer’s Disease
- Nausea & Vomiting
- Opioid Dependence Tests
- Other Indication
Key questions answered in this report
- What are the key micro and macro environmental factors that are impacting the growth of Oral Thin Film Drugs market?
- What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
- Estimated forecast and market projections up to 2031.
- Which segment accounts for the fastest CAGR during the forecast period?
- Which market segment holds a larger market share and why?
- Are low and middle-income economies investing in the Oral Thin Film Drugs market?
- Which is the largest regional market for Oral Thin Film Drugs market?
- What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
- Which are the key trends driving Oral Thin Film Drugs market growth?
- Who are the key competitors and what are their key strategies to enhance their market presence in the Oral Thin Film Drugs market worldwide?
This product will be delivered within 2 business days.
Table of Contents
1. Preface1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Oral Thin Film Drugs Market
2.2. Global Oral Thin Film Drugs Market, By Product, 2022 (US$ Million)
2.3. Global Oral Thin Film Drugs Market, By Indication, 2022 (US$ Million)
2.4. Global Oral Thin Film Drugs Market, By Geography, 2022 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2022
2.6. Key Buying Criteria
2.7. Key Case Reports
2.8. Scenario Analysis
2.8.1. Optimistic estimates and analysis
2.8.2. Realistic estimates and analysis
2.8.3. Pessimistic estimates and analysis
2.9. Market Profiling
2.10. Sales and Marketing Plan
2.11. Top Market Conclusions
2.12. Strategic Recommendations
3. Oral Thin Film Drugs Market: Competitive Analysis
3.1. Market Positioning of Key Oral Thin Film Drugs Market Vendors
3.2. Strategies Adopted by Oral Thin Film Drugs Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2022 Versus 2031
4. Oral Thin Film Drugs Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Oral Thin Film Drugs Market Value, 2021 - 2031, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter’s Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape
4.8. Heptalysis Analysis
4.9. Critical Investigation of Business Problems Through Five Whys Root Cause Analysis & Relevant Solutions
5. Oral Thin Film Drugs Market: By Product, 2021-2031, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2022 Versus 2031
5.3. Market Segmentation
5.3.1. Sublingual Film
5.3.2. Fully Dissolving Buccal Film
6. Oral Thin Film Drugs Market: By Indication, 2021-2031, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2022 Versus 2031
6.3. Market Segmentation
6.3.1. Migrainet
6.3.2. Schizophrenia
6.3.3. Alzheimer’s Disease
6.3.4. Nausea & Vomiting
6.3.5. Opioid Dependence Tests
6.3.6. Other Indication
7. Geographic Analysis
7.1. Market Overview
7.2.Macro Factors versus Market Impact: Dashboard, 2022
7.3. Porters Five Force Model Across Geography: Dashboard, 2022
7.4. Impact of PESTEL factors Across Geography: Dashboard, 2022
8. North America Oral Thin Film Drugs Market, 2021-2031, USD (Million)
8.1. Market Overview
8.2. Oral Thin Film Drugs Market: By Product, 2021-2031, USD (Million)
8.3. Oral Thin Film Drugs Market: By Indication, 2021-2031, USD (Million)
8.4.Oral Thin Film Drugs Market: By Region, 2021-2031, USD (Million)
8.4.1.North America
8.4.1.1. U.S.
8.4.1.1.1. Oral Thin Film Drugs Market: By Product, 2021-2031, USD (Million)
8.4.1.1.2. Oral Thin Film Drugs Market: By Indication, 2021-2031, USD (Million)
8.4.1.2. Canada
8.4.1.2.1. Oral Thin Film Drugs Market: By Product, 2021-2031, USD (Million)
8.4.1.2.2. Oral Thin Film Drugs Market: By Indication, 2021-2031, USD (Million)
8.4.1.3. Rest of North America
8.4.1.3.1. Oral Thin Film Drugs Market: By Product, 2021-2031, USD (Million)
8.4.1.3.2. Oral Thin Film Drugs Market: By Indication, 2021-2031, USD (Million)
9. UK and European Union Oral Thin Film Drugs Market, 2021-2031, USD (Million)
9.1. Market Overview
9.2. Oral Thin Film Drugs Market: By Product, 2021-2031, USD (Million)
9.3. Oral Thin Film Drugs Market: By Indication, 2021-2031, USD (Million)
9.4.Oral Thin Film Drugs Market: By Region, 2021-2031, USD (Million)
9.4.1.UK and European Union
9.4.1.1. UK
9.4.1.1.1. Oral Thin Film Drugs Market: By Product, 2021-2031, USD (Million)
9.4.1.1.2. Oral Thin Film Drugs Market: By Indication, 2021-2031, USD (Million)
9.4.1.2. Germany
9.4.1.2.1. Oral Thin Film Drugs Market: By Product, 2021-2031, USD (Million)
9.4.1.2.2. Oral Thin Film Drugs Market: By Indication, 2021-2031, USD (Million)
9.4.1.3. Spain
9.4.1.3.1. Oral Thin Film Drugs Market: By Product, 2021-2031, USD (Million)
9.4.1.3.2. Oral Thin Film Drugs Market: By Indication, 2021-2031, USD (Million)
9.4.1.4. Italy
9.4.1.4.1. Oral Thin Film Drugs Market: By Product, 2021-2031, USD (Million)
9.4.1.4.2. Oral Thin Film Drugs Market: By Indication, 2021-2031, USD (Million)
9.4.1.5. France
9.4.1.5.1. Oral Thin Film Drugs Market: By Product, 2021-2031, USD (Million)
9.4.1.5.2. Oral Thin Film Drugs Market: By Indication, 2021-2031, USD (Million)
9.4.1.6. Rest of Europe
9.4.1.6.1. Oral Thin Film Drugs Market: By Product, 2021-2031, USD (Million)
9.4.1.6.2. Oral Thin Film Drugs Market: By Indication, 2021-2031, USD (Million)
10. Asia Pacific Oral Thin Film Drugs Market, 2021-2031, USD (Million)
10.1. Market Overview
10.2. Oral Thin Film Drugs Market: By Product, 2021-2031, USD (Million)
10.3. Oral Thin Film Drugs Market: By Indication, 2021-2031, USD (Million)
10.4.Oral Thin Film Drugs Market: By Region, 2021-2031, USD (Million)
10.4.1.Asia Pacific
10.4.1.1. China
10.4.1.1.1. Oral Thin Film Drugs Market: By Product, 2021-2031, USD (Million)
10.4.1.1.2. Oral Thin Film Drugs Market: By Indication, 2021-2031, USD (Million)
10.4.1.2. Japan
10.4.1.2.1. Oral Thin Film Drugs Market: By Product, 2021-2031, USD (Million)
10.4.1.2.2. Oral Thin Film Drugs Market: By Indication, 2021-2031, USD (Million)
10.4.1.3. India
10.4.1.3.1. Oral Thin Film Drugs Market: By Product, 2021-2031, USD (Million)
10.4.1.3.2. Oral Thin Film Drugs Market: By Indication, 2021-2031, USD (Million)
10.4.1.4. Australia
10.4.1.4.1. Oral Thin Film Drugs Market: By Product, 2021-2031, USD (Million)
10.4.1.4.2. Oral Thin Film Drugs Market: By Indication, 2021-2031, USD (Million)
10.4.1.5. South Korea
10.4.1.5.1. Oral Thin Film Drugs Market: By Product, 2021-2031, USD (Million)
10.4.1.5.2. Oral Thin Film Drugs Market: By Indication, 2021-2031, USD (Million)
10.4.1.6. Rest of Asia Pacific
10.4.1.6.1. Oral Thin Film Drugs Market: By Product, 2021-2031, USD (Million)
10.4.1.6.2. Oral Thin Film Drugs Market: By Indication, 2021-2031, USD (Million)
11. Latin America Oral Thin Film Drugs Market, 2021-2031, USD (Million)
11.1. Market Overview
11.2. Oral Thin Film Drugs Market: By Product, 2021-2031, USD (Million)
11.3. Oral Thin Film Drugs Market: By Indication, 2021-2031, USD (Million)
11.4.Oral Thin Film Drugs Market: By Region, 2021-2031, USD (Million)
11.4.1.Latin America
11.4.1.1. Brazil
11.4.1.1.1. Oral Thin Film Drugs Market: By Product, 2021-2031, USD (Million)
11.4.1.1.2. Oral Thin Film Drugs Market: By Indication, 2021-2031, USD (Million)
11.4.1.2. Mexico
11.4.1.2.1. Oral Thin Film Drugs Market: By Product, 2021-2031, USD (Million)
11.4.1.2.2. Oral Thin Film Drugs Market: By Indication, 2021-2031, USD (Million)
11.4.1.3. Rest of Latin America
11.4.1.3.1. Oral Thin Film Drugs Market: By Product, 2021-2031, USD (Million)
11.4.1.3.2. Oral Thin Film Drugs Market: By Indication, 2021-2031, USD (Million)
12. Middle East and Africa Oral Thin Film Drugs Market, 2021-2031, USD (Million)
12.1. Market Overview
12.2. Oral Thin Film Drugs Market: By Product, 2021-2031, USD (Million)
12.3. Oral Thin Film Drugs Market: By Indication, 2021-2031, USD (Million)
12.4.Oral Thin Film Drugs Market: By Region, 2021-2031, USD (Million)
12.4.1.Middle East and Africa
12.4.1.1. GCC
12.4.1.1.1. Oral Thin Film Drugs Market: By Product, 2021-2031, USD (Million)
12.4.1.1.2. Oral Thin Film Drugs Market: By Indication, 2021-2031, USD (Million)
12.4.1.2. Africa
12.4.1.2.1. Oral Thin Film Drugs Market: By Product, 2021-2031, USD (Million)
12.4.1.2.2. Oral Thin Film Drugs Market: By Indication, 2021-2031, USD (Million)
12.4.1.3. Rest of Middle East and Africa
12.4.1.3.1. Oral Thin Film Drugs Market: By Product, 2021-2031, USD (Million)
12.4.1.3.2. Oral Thin Film Drugs Market: By Indication, 2021-2031, USD (Million)
13. Company Profile
13.1. Aquestive Therapeutics
13.1.1. Company Overview
13.1.2. Financial Performance
13.1.3. Product Portfolio
13.1.4. Strategic Initiatives
13.2. Tesa Labtec Gmbh
13.2.1. Company Overview
13.2.2. Financial Performance
13.2.3. Product Portfolio
13.2.4. Strategic Initiatives
13.3. Pfizer Inc
13.3.1. Company Overview
13.3.2. Financial Performance
13.3.3. Product Portfolio
13.3.4. Strategic Initiatives
13.4. Novartis AG
13.4.1. Company Overview
13.4.2. Financial Performance
13.4.3. Product Portfolio
13.4.4. Strategic Initiatives
13.5. Wolters Kluwer
13.5.1. Company Overview
13.5.2. Financial Performance
13.5.3. Product Portfolio
13.5.4. Strategic Initiatives
13.6. Solvay
13.6.1. Company Overview
13.6.2. Financial Performance
13.6.3. Product Portfolio
13.6.4. Strategic Initiatives
13.7. Allergan Plc
13.7.1. Company Overview
13.7.2. Financial Performance
13.7.3. Product Portfolio
13.7.4. Strategic Initiatives
13.8. Sumitomo Dainippon Pharma Co. Ltd
13.8.1. Company Overview
13.8.2. Financial Performance
13.8.3. Product Portfolio
13.8.4. Strategic Initiatives
13.9. Intelgenx Corp
13.9.1. Company Overview
13.9.2. Financial Performance
13.9.3. Product Portfolio
13.9.4. Strategic Initiatives
13.10. OPKO Health
13.10.1. Company Overview
13.10.2. Financial Performance
13.10.3. Product Portfolio
13.10.4. Strategic Initiatives
13.11. ZIM Laboratories Ltd.
13.11.1. Company Overview
13.11.2. Financial Performance
13.11.3. Product Portfolio
13.11.4. Strategic Initiatives
13.12. NAL Pharma
13.12.1. Company Overview
13.12.2. Financial Performance
13.12.3. Product Portfolio
13.12.4. Strategic Initiatives
13.13. CURE Pharmaceutical
13.13.1. Company Overview
13.13.2. Financial Performance
13.13.3. Product Portfolio
13.13.4. Strategic Initiatives
13.14. Kyu Kyu Pharmaceutical Co., Ltd.
13.14.1. Company Overview
13.14.2. Financial Performance
13.14.3. Product Portfolio
13.14.4. Strategic Initiatives
13.15. C.L.Pharm Co., Ltd.
13.15.1. Company Overview
13.15.2. Financial Performance
13.15.3. Product Portfolio
13.15.4. Strategic Initiatives
13.16. Others
13.16.1. Company Overview
13.16.2. Financial Performance
13.16.3. Product Portfolio
13.16.4. Strategic Initiatives
List of Figures
Figure 1 Global Oral Thin Film Drugs Market: Market Coverage
Figure 2 Research Methodology and Data Sources
Figure 3 Market Size Estimation - Top Down & Bottom-Up Approach
Figure 4 Global Oral Thin Film Drugs Market: Quality Assurance
Figure 5 Global Oral Thin Film Drugs Market, By Product, 2022
Figure 6 Global Oral Thin Film Drugs Market, By Indication, 2022
Figure 7 Global Oral Thin Film Drugs Market, By Geography, 2022
Figure 8 Market Geographical Opportunity Matrix - Global Oral Thin Film Drugs Market, 2022
Figure 9 Market Positioning of Key Oral Thin Film Drugs Market Players, 2022
Figure 10 Global Oral Thin Film Drugs Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031
Figure 11 Porters Five Force Model - Current, Midterm and Long Term Perspective
Figure 12 See Saw Analysis
Figure 13 PETEL Analysis
Figure 14 Key Buying Criteria: Current and Long-Term Perspective
Figure 15 Global Oral Thin Film Drugs Market, Scenario Analysis, 2021 to 2031 (US$ Million)
Figure 16 Heptalysis Analysis: Global Oral Thin Film Drugs Market
Figure 17 Five Whys Analysis
Figure 18 Global Oral Thin Film Drugs Market, By Product, 2022 Vs 2031, %
Figure 19 Global Oral Thin Film Drugs Market, By Indication, 2022 Vs 2031, %
Figure 20 U.S. Oral Thin Film Drugs Market (US$ Million), 2021 - 2031
Figure 21 Canada Oral Thin Film Drugs Market (US$ Million), 2021 - 2031
Figure 22 Rest of North America Oral Thin Film Drugs Market (US$ Million), 2021 - 2031
Figure 23 UK Oral Thin Film Drugs Market (US$ Million), 2021 - 2031
Figure 24 Germany Oral Thin Film Drugs Market (US$ Million), 2021 - 2031
Figure 25 Spain Oral Thin Film Drugs Market (US$ Million), 2021 - 2031
Figure 26 Italy Oral Thin Film Drugs Market (US$ Million), 2021 - 2031
Figure 27 France Oral Thin Film Drugs Market (US$ Million), 2021 - 2031
Figure 28 Rest of Europe Oral Thin Film Drugs Market (US$ Million), 2021 - 2031
Figure 29 China Oral Thin Film Drugs Market (US$ Million), 2021 - 2031
Figure 30 Japan Oral Thin Film Drugs Market (US$ Million), 2021 - 2031
Figure 31 India Oral Thin Film Drugs Market (US$ Million), 2021 - 2031
Figure 32 Australia Oral Thin Film Drugs Market (US$ Million), 2021 - 2031
Figure 33 South Korea Oral Thin Film Drugs Market (US$ Million), 2021 - 2031
Figure 34 Rest of Asia Oral Thin Film Drugs Market (US$ Million), 2021 - 2031
Figure 35 Brazil Oral Thin Film Drugs Market (US$ Million), 2021 - 2031
Figure 36 Mexico Oral Thin Film Drugs Market (US$ Million), 2021 - 2031
Figure 37 Rest of Latin America Oral Thin Film Drugs Market (US$ Million), 2021 - 2031
Figure 38 GCC Oral Thin Film Drugs Market (US$ Million), 2021 - 2031
Figure 39 Africa Oral Thin Film Drugs Market (US$ Million), 2021 - 2031
Figure 40 Rest of Middle East and Africa Oral Thin Film Drugs Market (US$ Million), 2021 - 2031
List of Tables
Table 1 Global Oral Thin Film Drugs Market By Product, 2021-2031, USD (Million)
Table 2 Global Oral Thin Film Drugs Market By Indication, 2021-2031, USD (Million)
Table 3 North America Oral Thin Film Drugs Market By Product, 2021-2031, USD (Million)
Table 4 North America Oral Thin Film Drugs Market By Indication, 2021-2031, USD (Million)
Table 5 U.S. Oral Thin Film Drugs Market By Product, 2021-2031, USD (Million)
Table 6 U.S. Oral Thin Film Drugs Market By Indication, 2021-2031, USD (Million)
Table 7 Canada Oral Thin Film Drugs Market By Product, 2021-2031, USD (Million)
Table 8 Canada Oral Thin Film Drugs Market By Indication, 2021-2031, USD (Million)
Table 9 Rest of North America Oral Thin Film Drugs Market By Product, 2021-2031, USD (Million)
Table 10 Rest of North America Oral Thin Film Drugs Market By Indication, 2021-2031, USD (Million)
Table 11 UK and European Union Oral Thin Film Drugs Market By Product, 2021-2031, USD (Million)
Table 12 UK and European Union Oral Thin Film Drugs Market By Indication, 2021-2031, USD (Million)
Table 13 UK Oral Thin Film Drugs Market By Product, 2021-2031, USD (Million)
Table 14 UK Oral Thin Film Drugs Market By Indication, 2021-2031, USD (Million)
Table 15 Germany Oral Thin Film Drugs Market By Product, 2021-2031, USD (Million)
Table 16 Germany Oral Thin Film Drugs Market By Indication, 2021-2031, USD (Million)
Table 17 Spain Oral Thin Film Drugs Market By Product, 2021-2031, USD (Million)
Table 18 Spain Oral Thin Film Drugs Market By Indication, 2021-2031, USD (Million)
Table 19 Italy Oral Thin Film Drugs Market By Product, 2021-2031, USD (Million)
Table 20 Italy Oral Thin Film Drugs Market By Indication, 2021-2031, USD (Million)
Table 21 France Oral Thin Film Drugs Market By Product, 2021-2031, USD (Million)
Table 22 France Oral Thin Film Drugs Market By Indication, 2021-2031, USD (Million)
Table 23 Rest of Europe Oral Thin Film Drugs Market By Product, 2021-2031, USD (Million)
Table 24 Rest of Europe Oral Thin Film Drugs Market By Indication, 2021-2031, USD (Million)
Table 25 Asia Oral Thin Film Drugs Market By Product, 2021-2031, USD (Million)
Table 26 Asia Oral Thin Film Drugs Market By Indication, 2021-2031, USD (Million)
Table 27 China Oral Thin Film Drugs Market By Product, 2021-2031, USD (Million)
Table 28 China Oral Thin Film Drugs Market By Indication, 2021-2031, USD (Million)
Table 29 Japan Oral Thin Film Drugs Market By Product, 2021-2031, USD (Million)
Table 30 Japan Oral Thin Film Drugs Market By Indication, 2021-2031, USD (Million)
Table 31 India Oral Thin Film Drugs Market By Product, 2021-2031, USD (Million)
Table 32 India Oral Thin Film Drugs Market By Indication, 2021-2031, USD (Million)
Table 33 Australia Oral Thin Film Drugs Market By Product, 2021-2031, USD (Million)
Table 34 Australia Oral Thin Film Drugs Market By Indication, 2021-2031, USD (Million)
Table 35 South Korea Oral Thin Film Drugs Market By Product, 2021-2031, USD (Million)
Table 36 South Korea Oral Thin Film Drugs Market By Indication, 2021-2031, USD (Million)
Table 37 Latin America Oral Thin Film Drugs Market By Product, 2021-2031, USD (Million)
Table 38 Latin America Oral Thin Film Drugs Market By Indication, 2021-2031, USD (Million)
Table 39 Brazil Oral Thin Film Drugs Market By Product, 2021-2031, USD (Million)
Table 40 Brazil Oral Thin Film Drugs Market By Indication, 2021-2031, USD (Million)
Table 41 Mexico Oral Thin Film Drugs Market By Product, 2021-2031, USD (Million)
Table 42 Mexico Oral Thin Film Drugs Market By Indication, 2021-2031, USD (Million)
Table 43 Rest of Latin America Oral Thin Film Drugs Market By Product, 2021-2031, USD (Million)
Table 44 Rest of Latin America Oral Thin Film Drugs Market By Indication, 2021-2031, USD (Million)
Table 45 Middle East and Africa Oral Thin Film Drugs Market By Product, 2021-2031, USD (Million)
Table 46 Middle East and Africa Oral Thin Film Drugs Market By Indication, 2021-2031, USD (Million)
Table 47 GCC Oral Thin Film Drugs Market By Product, 2021-2031, USD (Million)
Table 48 GCC Oral Thin Film Drugs Market By Indication, 2021-2031, USD (Million)
Table 49 Africa Oral Thin Film Drugs Market By Product, 2021-2031, USD (Million)
Table 50 Africa Oral Thin Film Drugs Market By Indication, 2021-2031, USD (Million)
Table 51 Rest of Middle East and Africa Oral Thin Film Drugs Market By Product, 2021-2031, USD (Million)
Table 52 Rest of Middle East and Africa Oral Thin Film Drugs Market By Indication, 2021-2031, USD (Million)
Companies Mentioned
- Aquestive Therapeutics
- Tesa Labtec Gmbh
- Pfizer Inc
- Novartis AG
- Wolters Kluwer
- Solvay
- Allergan Plc
- Sumitomo Dainippon Pharma Co. Ltd
- Intelgenx Corp
- OPKO Health
- ZIM Laboratories Ltd
- NAL Pharma
- CURE Pharmaceutical
- Kyu Kyu Pharmaceutical Co Ltd
- C.L.Pharm Co Ltd.
